Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012-2020 Period Analysis.

Lecai, Ji; Mijiti, Peierdun; Chuangyue, Hong; Mingzhen, Li; Qian, Gao; Weiguo, Tan; Jihong, Chen

Lecai, Ji; Mijiti, Peierdun; Chuangyue, Hong; Mingzhen, Li; Qian, Gao; Weiguo, Tan; Jihong, Chen.

Affiliation

Lecai J; Department of Nephrology, Affiliated Bao'an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, 518101, People's Republic of China.
Mijiti P; Department of Tuberculosis, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, Guangdong, People's Republic of China.
Chuangyue H; The Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Science, Fudan University, Shanghai, 200032, People's Republic of China.
Mingzhen L; Department of Tuberculosis, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, Guangdong, People's Republic of China.
Qian G; Department of Tuberculosis, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, Guangdong, People's Republic of China.
Weiguo T; The Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Science, Fudan University, Shanghai, 200032, People's Republic of China.
Jihong C; Department of Tuberculosis, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, Guangdong, People's Republic of China.

Infect Drug Resist ; 14: 4481-4491, 2021.

Article de En | MEDLINE | ID: mdl-34737588

Mots clés

20122020; MDR/RR-TB; Shenzhen; predictors; trend

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Infect Drug Resist Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google